| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1374654 | Bioorganic & Medicinal Chemistry Letters | 2010 | 5 Pages |
Abstract
The union of HCV-796, a potent selective HCV NS5B polymerase inhibitor, and Ribavirin, a molecule with activities against a wide spectrum of viruses, resulted in a class of new anti-HCV agents with a sequential triple inhibitory mechanism.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Tianmin Zhu, Mahdi B. Fawzi, Michael Flint, Fangming Kong, Jan Szeliga, Russ Tsao, Anita Y.M. Howe, Weitao Pan,